Chronic urotensin II receptor antagonist treatment does not alter hypertrophy or fibrosis in a rat model of pressure-overload hypertrophy
Andrew R Kompa, Bing H Wang, Arintaya Phrommintikul, Pei Y Ho, Darren J Kelly, David J Behm, Stephen A Douglas, Henry Krum
Peptides | ELSEVIER SCIENCE INC | Published : 2010
Awarded by National Health and Medical Research Council of Australia
This study was supported by GlaxoSmithKline and National Health and Medical Research Council of Australia grants  and . The authors would also like to thank GSK for the gift of compound SB-657510, Dr. Chris Evans (GSK) for measurement of plasma levels of SB-657510, and Ms. Mariana Pacheco, Ms. Jemma Court and Ms. Gordana Kel for technical support with the animal studies.